Frida Abel

Visar 23 publikationer

2016

Malignant pheochromocytomas/paragangliomas harbor mutations in transport and cell adhesion genes.

Annica Wilzén, Anna Rehammar, Andreas Muth et al
International Journal of Cancer. Vol. 138 (9), p. 2201-11
Artikel i vetenskaplig tidskrift
2013

ERBB3 is a marker of a ganglioneuroblastoma/ganglioneuroma-like expression profile in neuroblastic tumours.

Annica Wilzén, Cecilia Krona, Baldur Sveinbjörnsson et al
Molecular Cancer. Vol. 12 (July 2013), p. artikel nr 70-
Artikel i vetenskaplig tidskrift
2013

Stage-dependent expression of PI3K/Akt‑pathway genes in neuroblastoma.

Susanne Fransson, Frida Abel, Per Kogner et al
International journal of oncology. Vol. 42 (2), p. 609-16
Artikel i vetenskaplig tidskrift
2013

Expression of TWEAK/Fn14 in neuroblastoma: Implications in tumorigenesis

I. Pettersen, N. Baryawno, Frida Abel et al
International Journal of Oncology. Vol. 42 (4), p. 1239-1248
Artikel i vetenskaplig tidskrift
2012

Prevalence of Germline Mutations in Patients with Pheochromocytoma or Abdominal Paraganglioma and Sporadic Presentation: A Population-Based Study in Western Sweden.

Andreas Muth, Frida Abel, Svante Jansson et al
World Journal of Surgery. Vol. 36 (6), p. 1389-94
Artikel i vetenskaplig tidskrift
2011

A 6-gene signature identifies four molecular subgroups of neuroblastoma

Frida Abel, Daniel Dalevi, Maria Nethander et al
Cancer Cell International. Vol. 11 (9)
Artikel i vetenskaplig tidskrift
2009

The Phox2 pathway is differentially expressed in neuroblastoma tumors, but no mutations were found in the candidate tumor suppressor gene PHOX2A.

Annica Wilzén, Staffan Nilsson, Rose-Marie Sjöberg et al
International Journal of Oncology. Vol. 34 (3), p. 697-705
Artikel i vetenskaplig tidskrift
2009

Verification of genes differentially expressed in neuroblastoma tumours: a study of potential tumour suppressor genes.

Kaisa Thorell, Annika Bergman, Helena Carén et al
BMC Medical Genomics. Vol. 2 (1), p. 53-
Artikel i vetenskaplig tidskrift
2008

Gene expression variation to predict 10-year survival in lymph-node-negative breast cancer.

Elin Karlsson, Ulla Delle, Anna Danielsson et al
BMC Cancer. Vol. 8, p. 254-
Artikel i vetenskaplig tidskrift
2008

No germline mutations in supposed tumour suppressor genes SAFB1 and SAFB2 in familial breast cancer with linkage to 19p

Annika Bergman, Frida Abel, Afrouz Behboudi et al
BMC Medical Genetics. Vol. 9 (1), p. 108-
Artikel i vetenskaplig tidskrift
2008

High incidence of DNA mutations and gene amplifications of the ALK gene in advanced sporadic neuroblastoma tumours

Helena Carén, Frida Abel, Per Kogner et al
Biochemical Journal. Vol. 416 (2), p. 153-159
Artikel i vetenskaplig tidskrift
2008

High incidence of DNA mutations and gene amplifications of the ALK gene in advanced sporadic neuroblastoma tumours.

Helena Carén, Frida Abel, Per Kogner et al
Biochemical Journal. Vol. 416 (2), p. 153-9
Artikel i vetenskaplig tidskrift
2006

Significant Decrease in mRNA Expression of Five Genes Mapped at 1p36.2, comparing Favorable and Unfavorable Neuroblastomas.

Susanne Fransson, Cecilia Krona, Rose-Marie Sjöberg et al
Advances in Neuroblastoma Research 2006, Los Angeles, USA, 2006
Konferensbidrag (offentliggjort, men ej förlagsutgivet)
2005

Imbalance of the mitochondrial pro- and anti-apoptotic mediators in neuroblastoma tumours with unfavourable biology.

Frida Abel, Rose-Marie Sjöberg, Staffan Nilsson et al
European Journal of Cancer. Vol. 41 (4), p. 635-46
Artikel i vetenskaplig tidskrift
2004

A novel 1p36.2 located gene, APITD1, with tumour-suppressive properties and a putative p53-binding domain, shows low expression in neuroblastoma tumours.

Cecilia Krona, Katarina Ejeskär, Helena Carén et al
British Journal of Cancer. Vol. 91 (6), p. 1119-30
Artikel i vetenskaplig tidskrift
2004

Mutations in the N-terminal domain of DFF45 in a primary germ cell tumor and in neuroblastoma tumors.

Frida Abel, Rose-Marie Sjöberg, Cecilia Krona et al
International Journal of Oncology. Vol. 25 (5), p. 1297-302
Artikel i vetenskaplig tidskrift
2004

Investigation of the role of SDHB inactivation in sporadic phaeochromocytoma and neuroblastoma.

D Astuti, M Morris, Cecilia Krona et al
British Journal of Cancer. Vol. 91 (10), p. 1835-41
Artikel i vetenskaplig tidskrift
2003

Screening for gene mutations in a 500 kb neuroblastoma tumor suppressor candidate region in chromosome 1p; mutation and stage-specific expression in UBE4B/UFD2.

Cecilia Krona, Katarina Ejeskär, Frida Abel et al
Oncogene. Vol. 22 (15), p. 2343-51
Artikel i vetenskaplig tidskrift
2002

Analyses of apoptotic regulators CASP9 and DFFA at 1P36.2, reveal rare allele variants in human neuroblastoma tumours.

Frida Abel, Rose-Marie Sjöberg, Katarina Ejeskär et al
British Journal of Cancer. Vol. 86 (4), p. 596-604
Artikel i vetenskaplig tidskrift
2001

Fine mapping of a tumour suppressor candidate gene region in 1p36.2-3, commonly deleted in neuroblastomas and germ cell tumours.

Katarina Ejeskär, Rose-Marie Sjöberg, Frida Abel et al
Medical and Pediatric Oncology. Vol. 36 (1), p. 61-6
Artikel i vetenskaplig tidskrift
2000

Fine mapping of the human preprocortistatin gene (CORT) to neuroblastoma consensus deletion region 1p36.3-->p36.2, but absence of mutations in primary tumors.

Katarina Ejeskär, Frida Abel, Rose-Marie Sjöberg et al
Cytogenetics and Cell Genetics. Vol. 89 (1-2), p. 62-6
Artikel i vetenskaplig tidskrift
1999

Gain of chromosome arm 17q is associated with unfavourable prognosis in neuroblastoma, but does not involve mutations in the somatostatin receptor 2(SSTR2) gene at 17q24.

Frida Abel, Katarina Ejeskär, Per Kogner et al
British Journal of Cancer. Vol. 81 (8), p. 1402-9
Artikel i vetenskaplig tidskrift

Spara referenser

Om du har installerat Zotero eller Mendeley på din dator kan du direkt ta ut referenser från de publikationer du ser i listan.

Du laddar ner dessa pluginer här:
Zotero
Mendeley

Det finns inga projekt att visa.
Det kan finnas fler projekt där Frida Abel medverkar, men du måste vara inloggad som anställd på Chalmers för att kunna se dem.